Table: Cosmos Pharmaceutical - 9-MTH group results

Cosmos Pharmaceutical

13/04/2020 07:00

Apr 13 (Reuters)- 
             Cosmos Pharmaceutical Corp. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Feb 29, 2020        Feb 28, 2019     May 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            492.88              450.49           658.50    
                 (+9.4 pct)          (+9.7 pct)       (+7.7 pct)  
  Operating         19.43               18.03            24.80    
                 (+7.8 pct)          (+14.2 pct)      (+0.1 pct)  
  Recurring         21.20               19.69            27.30    
                 (+7.7 pct)          (+11.5 pct)      (+0.0 pct)  
  Net               14.24               13.21            19.19    
                 (+7.8 pct)          (+11.2 pct)      (+0.0 pct)  
  EPS            719.17 yen          667.09 yen       969.21 yen  
  Ann Div                            100.00 yen       100.00 yen  
  -Q2 div         50.00 yen           45.00 yen                   
  -Q4 div                             55.00 yen        50.00 yen  
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T